⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Arya Pharmaceuticals
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Arya Pharmaceuticals just got measured.
5/10 means Arya Pharmaceuticals is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About Arya Pharmaceuticals
Arya Pharmaceuticals is developing ARYA-24, a first-in-class small molecule designed in silico to target a novel transcription factor, with 93% AML cytotoxicity in NCI-60 testing, 2x venetoclax. Composition-of-matter IP through 2046 and orphan drug eligibility. Partnering and licensing inquiries welcome.
Key Topics
Details
AI Visibility Breakdown
4
Structured Data
7
Content Structure
7
Entity Clarity
3
E-E-A-T Signals
6
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Trust Is the Product. AI Is How You Build It at Scale.
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Arya Pharmaceuticals.
Source & Attribution
Scored by Engagemii on June 28, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/aryapharmaceuticals
Cite this score: Engagemii (2026). "AEO Score for Arya Pharmaceuticals." Retrieved from https://engagemii.com/aeo/brands/aryapharmaceuticals
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform